Related Experiment Video

Updated: Aug 21, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

CHF: "compressive" heart failure? A clinical review of metastatic cardiac tumors

Senthil Nachimuthu1, Patricia A Uber, Priyankha Balasundaram

  • 1Oschner Cardiomyopathy and Heart Transplantation Center, Oschsner Clinic Foundation, New Orleans, LA 70121, USA.

Congestive Heart Failure (Greenwich, Conn.)
|October 8, 2004
PubMed

Insights

Malignant neoplasms frequently metastasize to the heart, causing cardiac metastasis. This metastatic heart disease is more common than primary tumors and leads to worse patient prognosis.

Area of Science:

  • Cardiology
  • Oncology
  • Pathology

Background:

  • Cardiac metastasis occurs in nearly 10% of patients with malignant neoplasms.
  • Metastatic heart disease is more prevalent than primary cardiac tumors.
  • Malignant cardiac tumors are associated with a poorer prognosis.

Observation:

  • A case of mitral inflow obstruction caused by metastatic malignancy to the left atrium is presented.
  • This obstruction resulted in "compressive" heart failure.
  • The clinical presentation and management of such cases are discussed.

Findings:

  • Metastatic malignancy to the heart can lead to significant hemodynamic compromise.
  • Left atrial metastasis can obstruct mitral inflow, causing heart failure.
  • Early recognition and management are crucial for improving outcomes.

Implications:

  • Highlights the importance of considering cardiac metastasis in cancer patients presenting with heart failure symptoms.
  • Emphasizes the need for advanced imaging and diagnostic techniques to detect cardiac involvement.
  • Underscores the poor prognosis associated with metastatic heart disease, necessitating multidisciplinary care approaches.

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...